Merck compra Schering por $ 41.1 Billion

Merck, the American pharmaceutical giant, will pay $41 billion to acquire a rival Schering-Plough, the two companies said Monday.

The companies said in a joint statement that the merged company would keep the name Merck, and that the deal had been unanimously approved by their boards. Richard T. Clark, Merck’s chairman and chief executive, will lead the combined company.

Mas...